.Vertex has actually stated period 3 data on its near-approval ache medicine prospect suzetrigine, clarifying how the non-opioid painkiller blends with ibuprofen and why the
Read moreCognition’s stage 2 SHINE records stain Alzheimer’s prospect
.Cognition Therapeutics’ stage 2 luster trial has actually taken several of the appeal off the Alzheimer’s health condition drug candidate CT1812. The oral sigma-2 antagonist
Read moreChutes & Ladders– Gilead’s Merdad Parsey goes, Cassava drops chief executive officer
.Invite to today’s Chutes & Ladders, our roundup of notable management hirings, shootings and retirings across the sector. Please send the good word– or the
Read moreChinese blood insulin producer’s GLP-1 finests Ozempic in ph. 2
.Mandarin blood insulin creator Gan & Lee Pharmaceuticals is actually wading into the obesity world along with an injectable GLP-1 agonist that beat Novo Nordisk’s
Read moreChina- based biotech strategies ph. 3 after viewing midstage eye data
.China-based Minghui Pharmaceutical has actually connected its thyroid eye condition therapy to a reduction in eye protruding in a small period 1b/2 medical test.The research
Read moreCharles Baum takes control of Terremoto as CEO
.Charles Baum, M.D., Ph.D., who managed Mirati Therapeutics’ $ 5.8 billion purchase to Bristol Myers Squibb in 2015, is actually taking the command of young
Read moreCelldex anti-cKIT antitoxin reduce hives in another stage 2 research study
.It’s difficult to muscle mass in on a space as very competitive as immunology, but Celldex Therapies feels that its most up-to-date stage 2 win
Read moreCell- concentrated Sana gathers 1st CSO– Chutes & Ladders
.Invite to recently’s Chutes & Ladders, our summary of considerable leadership hirings, shootings as well as retirings all over the business. Satisfy deliver the recommendation–
Read moreCassava pays for $40M over purportedly deceiving Alzheimer’s update
.Cassava Sciences has actually agreed to pay $40 thousand to solve an examination in to insurance claims it created deceptive claims about stage 2b information
Read moreCash- strapped Gritstone starts look for key choices as cancer vaccination records underwhelm
.Gritstone bio has produced banks to look into “possible value-maximizing strategies” after its stage 2 colon cancer cells vaccine records fell short of the loose
Read more